Literature DB >> 21150369

Mountain States Genetics Regional Collaborative Center's Metabolic Newborn Screening Long-term Follow-up Study: a collaborative multi-site approach to newborn screening outcomes research.

Erica L Wright1, Johan L K Van Hove, Janet Thomas.   

Abstract

PURPOSE: This article presents the rationale and design of the Mountain States Genetics Regional Collaborative Center's Metabolic Newborn Screening Long-Term Follow-up Study.
METHODS: This study is a collaboration of multi-site metabolic providers throughout the Mountain States region investigating the long-term outcomes of individuals with metabolic conditions detected by newborn screening.
RESULTS: The Mountain States Genetics Regional Collaborative Center's Metabolic Consortium developed disease-specific care plans that included baseline and follow-up datasets for all metabolic disorders detected by both standard and tandem mass spectrometry newborn screening.
CONCLUSION: These disease-specific care plans are used at multiple metabolic clinics throughout the Mountain States region. The shared datasets consisting of both performance and outcome indicators will be used to explore questions related to the treatment and outcome of these rare metabolic disorders. They will be used to assess the impact of newborn screening by comparing those individuals detected by newborn screening with those individuals diagnosed clinically, therefore allowing the systematic investigation of factors that impact long-term outcome.

Entities:  

Mesh:

Year:  2010        PMID: 21150369     DOI: 10.1097/GIM.0b013e3181fe5d50

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  3 in total

1.  Molecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  Manuel Schiff; Al-Walid Mohsen; Anuradha Karunanidhi; Elizabeth McCracken; Renita Yeasted; Jerry Vockley
Journal:  Mol Genet Metab       Date:  2013-02-13       Impact factor: 4.797

2.  A framework for assessing outcomes from newborn screening: on the road to measuring its promise.

Authors:  Cynthia F Hinton; Charles J Homer; Alexis A Thompson; Andrea Williams; Kathryn L Hassell; Lisa Feuchtbaum; Susan A Berry; Anne Marie Comeau; Bradford L Therrell; Amy Brower; Katharine B Harris; Christine Brown; Jana Monaco; Robert J Ostrander; Alan E Zuckerman; Celia Kaye; Denise Dougherty; Carol Greene; Nancy S Green
Journal:  Mol Genet Metab       Date:  2016-05-31       Impact factor: 4.797

3.  Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings.

Authors:  Cynthia F Hinton; Cara T Mai; Sarah K Nabukera; Lorenzo D Botto; Lisa Feuchtbaum; Paul A Romitti; Ying Wang; Kimberly Noble Piper; Richard S Olney
Journal:  Genet Med       Date:  2013-12-05       Impact factor: 8.822

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.